Figure 2
Figure 2. B-cell development is arrested at the pre–pro-B to pro–B-cell transition in the absence of NF-κB2/p100. (A) Schematic illustration of B-cell development in bone marrow. The expression of characteristic cell surface proteins for successive progenitor stages in mouse B lymphopoiesis are indicated. Lin−, negative for the expression of lineage-specific markers (CD3ε−CD8α−CD19−DX5−Gr-1−Ly6C−Mac-1−Ter119−). (B) Flow cytometric analysis of c-Kit and B220 expression on Lin−CD19− wild-type and p100−/− bone marrow to define pre–pro-B cells (Fr. A). (C) Analysis of CD19 and B220 expression on c-Kit+CD43+ wild-type and p100−/− bone marrow to define pro-B cells (Fr. B/C). (D) Analysis of CD19 and CD25 expression on IgM− wild-type and p100−/− bone marrow to define pre-B cells (Fr. C-prime/D). (E) Analysis of CD19+IgMhigh immature B cells (Fr. E) in wild-type and p100−/− bone marrow. Percentages of relevant populations are indicated. Numbers represent mean values (± SD) from 5 mice.

B-cell development is arrested at the pre–pro-B to pro–B-cell transition in the absence of NF-κB2/p100. (A) Schematic illustration of B-cell development in bone marrow. The expression of characteristic cell surface proteins for successive progenitor stages in mouse B lymphopoiesis are indicated. Lin, negative for the expression of lineage-specific markers (CD3εCD8αCD19DX5Gr-1Ly6CMac-1Ter119). (B) Flow cytometric analysis of c-Kit and B220 expression on LinCD19 wild-type and p100−/− bone marrow to define pre–pro-B cells (Fr. A). (C) Analysis of CD19 and B220 expression on c-Kit+CD43+ wild-type and p100−/− bone marrow to define pro-B cells (Fr. B/C). (D) Analysis of CD19 and CD25 expression on IgM wild-type and p100−/− bone marrow to define pre-B cells (Fr. C-prime/D). (E) Analysis of CD19+IgMhigh immature B cells (Fr. E) in wild-type and p100−/− bone marrow. Percentages of relevant populations are indicated. Numbers represent mean values (± SD) from 5 mice.

Close Modal

or Create an Account

Close Modal
Close Modal